her2 mbc: addressing ild in the destiny-breast01 study
Published 4 years ago • 144 plays • Length 4:34Download video MP4
Download video MP3
Similar videos
-
4:56
her2 mbc: study design and results of destiny-breast01
-
3:31
hope rugo, md, examines data from the destiny-breast01 clinical study presented at sabcs 2020
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
1:33
destiny-breast01: a new “destiny” for her2positive mbc patients?
-
6:29
evolving treatment landscape of r/r her2 mbc
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
33:34
sharing my her2 breast cancer diagnosis story at 35 years old
-
11:12
her2-low breast cancer: destiny or good science?
-
1:52
her2 mbc: safety and tolerability in her2climb
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
3:59
emerging data for the treatment of her2 mbc
-
2:53
unmet needs in the management of her2 mbc
-
1:07
dr. hamilton on the destiny-breast01 trial in her2 breast cancer
-
1:42
dr. dang on the destiny-breast01 trial in her2 metastatic breast cancer
-
1:22
dr. hurvitz on the findings of destiny-breast01 in her2 metastatic breast cancer
-
3:45
her2climb: implications for brain metastases in her2 mbc
-
56:42
research update for her2-positive mbc | 2021-2022 embrace mbc virtual forum series
-
4:05
sophia trial in r/r her2 mbc
-
2:41
dr tarantino on the safety of t-dxd and t-dm1 in her2 breast cancer
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
1:13
dr. hurvitz on using adcs in her2 breast cancer